Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity.
about
Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity.
@en
Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity.
@nl
type
label
Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity.
@en
Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity.
@nl
prefLabel
Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity.
@en
Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity.
@nl
P2860
P921
P356
P1476
Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity.
@en
P2093
Ananthi Anandhakrishnan
Márta Korbonits
P2860
P304
P356
10.4239/WJD.V7.I20.572
P577
2016-12-01T00:00:00Z